Literature DB >> 11128726

Low-density lipoprotein cholesterol in subclinical hypothyroidism.

H Vierhapper1, A Nardi, P Grösser, W Raber, A Gessl.   

Abstract

The significance of subclinical hypothyroidism in regard to ensuing hyperlipidemia remains unclear. Because an unfavorable lipid profile would provide a possible explanation for the reported association of coronary-heart disease with this syndrome, we have evaluated the relationship of thyrotropin (TSH) with total cholesterol, low-density-lipoprotein (LDL) cholesterol, and triglycerides in patients with normal thyroid function (n = 4886) as well as subclinical (n = 1055) and manifest (n = 92) hypothyroidism. Serum concentrations of LDL cholesterol were similar in euthyroid persons (134+/-39 mg/dL) and in patients with subclinical hypothyroidism (137+/-40 mg/dL) but were higher (178+/-70 mg/dL, p < 0.01) in overt hypothyroidism. Within the group of subjects with subclinical hypothyroidism there was no apparent relationship between serum concentrations of TSH ranging from 4.0 to 49.0 microU/mL and concentrations of LDL cholesterol. Thus, there is no "threshold value" of TSH in these patients per se necessitating substitution therapy with thyroxine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11128726     DOI: 10.1089/thy.2000.10.981

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  18 in total

1.  High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease.

Authors:  A C Hauser; A Gessl; M Lorenz; T Voigtländer; M Födinger; G Sunder-Plassmann
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Coronary flow reserve is impaired in subclinical hypothyroidism.

Authors:  Semra Baycan; Dogan Erdogan; Mustafa Caliskan; Baris Onder Pamuk; Ozgur Ciftci; Hakan Gullu; Aylin Yildirir; Nilgun D Guvener; Haldun Muderrisoglu
Journal:  Clin Cardiol       Date:  2007-11       Impact factor: 2.882

3.  The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism.

Authors:  R Serter; B Demirbas; B Korukluoglu; C Culha; E Cakal; Y Aral
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

Review 4.  Hypothyroidism and dyslipidemia: modern concepts and approaches.

Authors:  Elizabeth N Pearce
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

5.  Subclinical hypothyroidism and the risk of hypercholesterolemia.

Authors:  William J Hueston; William S Pearson
Journal:  Ann Fam Med       Date:  2004 Jul-Aug       Impact factor: 5.166

6.  Menopause modulates the association between thyrotropin levels and lipid parameters: The SardiNIA study.

Authors:  Alessandro P Delitala; Maristella Steri; Maria Grazia Pilia; Mariano Dei; Sandra Lai; Giuseppe Delitala; David Schlessinger; Francesco Cucca
Journal:  Maturitas       Date:  2016-07-14       Impact factor: 4.342

7.  Differences in DBA/1J and DBA/2J reveal lipid QTL genes.

Authors:  Ioannis M Stylianou; Sarah R Langley; Kenneth Walsh; Yuan Chen; Céline Revenu; Beverly Paigen
Journal:  J Lipid Res       Date:  2008-05-23       Impact factor: 5.922

8.  Thyroid stimulating hormone, independent of thyroid hormone, can elevate the serum total cholesterol level in patients with coronary heart disease: a cross-sectional design.

Authors:  Chao Xu; Xiaomei Yang; Wenhui Liu; Haitao Yuan; Chunxiao Yu; Ling Gao; Jiajun Zhao
Journal:  Nutr Metab (Lond)       Date:  2012-05-23       Impact factor: 4.169

9.  Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea.

Authors:  Chan Hee Jung; Ki Chul Sung; Hun Sub Shin; Eun Jung Rhee; Won Young Lee; Bum Soo Kim; Jin Ho Kang; Hyang Kim; Sun Woo Kim; Man Ho Lee; Jung Ro Park; Seon Woo Kim
Journal:  Korean J Intern Med       Date:  2003-09       Impact factor: 2.884

10.  LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation.

Authors:  Kexi Zha; Changting Zuo; Aihong Wang; Bingchang Zhang; Yan Zhang; Bei Wang; Yunjia Wang; Jiajun Zhao; Ling Gao; Chao Xu
Journal:  Lipids Health Dis       Date:  2015-08-25       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.